Jiatong Li
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Research advances in evaluation methods for neoadjuvant therapy of tumors.
Journal: Frontiers in oncology
Published: February 20, 2025
Patient-derived xenograft model in cancer: establishment and applications.
Journal: MedComm
Published: July 04, 2024
Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma.
Journal: Frontiers in immunology
Published: June 07, 2024
Global research development of chondrosarcoma from 2003 to 2022: a bibliometric analysis.
Journal: Frontiers in pharmacology
Published: May 13, 2024
FBXO22 promotes osteosarcoma progression via regulation of FOXO1 for ubiquitination and degradation.
FBXO22 promotes osteosarcoma progression via regulation of FOXO1 for ubiquitination and degradation.
Journal: Journal of cellular and molecular medicine
Published: April 23, 2024
PROTACs: Novel tools for improving immunotherapy in cancer.
Journal: Cancer letters
Published: January 25, 2023
The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy.
Journal: Frontiers in immunology
Published: December 13, 2022
Long Intergenic Noncoding RNA00265 Enhances Cell Viability and Metastasis via Targeting miR-485-5p/USP22 Axis in Osteosarcoma.
Journal: Frontiers in oncology
Published: March 29, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026